pyrazolanthrone has been researched along with undecylprodigiosin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alfonso, A; Alonso, E; Botana, LM; Ebel, R; Jaspars, M; Leirós, M; Rateb, ME | 1 |
1 other study(ies) available for pyrazolanthrone and undecylprodigiosin
| Article | Year |
|---|---|
The Streptomyces metabolite anhydroexfoliamycin ameliorates hallmarks of Alzheimer's disease in vitro and in vivo.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Anthracenes; Antipsychotic Agents; Aspartic Acid Endopeptidases; Brain; Cell Line, Tumor; Disease Models, Animal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; MAP Kinase Kinase Kinases; Mice; Mice, Transgenic; Mutation; Neuroblastoma; Peptide Fragments; Presenilin-1; Prodigiosin; tau Proteins | 2015 |